Ivermectin: an anthelmintic, an insecticide, and much more
Here we tell the story of ivermectin, describing its anthelmintic and insecticidal actions and
recent studies that have sought to reposition ivermectin for the treatment of other diseases …
recent studies that have sought to reposition ivermectin for the treatment of other diseases …
[HTML][HTML] Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
V Hiebl, A Ladurner, S Latkolik, VM Dirsch - Biotechnology advances, 2018 - Elsevier
Nuclear receptors (NRs) represent attractive targets for the treatment of metabolic syndrome-
related diseases. In addition, natural products are an interesting pool of potential ligands …
related diseases. In addition, natural products are an interesting pool of potential ligands …
Performance of HADDOCK and a simple contact-based protein–ligand binding affinity predictor in the D3R Grand Challenge 2
Z Kurkcuoglu, PI Koukos, N Citro, ME Trellet… - Journal of computer …, 2018 - Springer
We present the performance of HADDOCK, our information-driven docking software, in the
second edition of the D3R Grand Challenge. In this blind experiment, participants were …
second edition of the D3R Grand Challenge. In this blind experiment, participants were …
The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism
Farnesoid X receptor (FXR) has important roles in maintaining bile acid and cholesterol
homeostasis. Here we report that the antiparasitic drug ivermectin is a ligand for nuclear …
homeostasis. Here we report that the antiparasitic drug ivermectin is a ligand for nuclear …
Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin
IS Chen, Y Kubo - The Journal of physiology, 2018 - Wiley Online Library
Ivermectin (IVM) is an antiparasitic drug that is used worldwide and rescues hundreds of
millions of people from onchocerciasis and lymphatic filariasis. It was discovered by Satoshi …
millions of people from onchocerciasis and lymphatic filariasis. It was discovered by Satoshi …
Recent advances in the medicinal chemistry of farnesoid X receptor
Farnesoid X receptor (FXR) is an important regulator of bile acid, lipid, amino acid, and
glucose homeostasis, hepatic inflammation, regeneration, and fibrosis. FXR has been …
glucose homeostasis, hepatic inflammation, regeneration, and fibrosis. FXR has been …
New insights in the multiple roles of bile acids and their signaling pathways in metabolic control
JF de Boer, VW Bloks, E Verkade… - Current Opinion in …, 2018 - journals.lww.com
Specific bile acids and their signaling pathways play important roles in control of
(cholesterol) metabolism. Deeper insight into the interactions between endogenous (ie, bile …
(cholesterol) metabolism. Deeper insight into the interactions between endogenous (ie, bile …
Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms
DAA Hollman, A Milona, KJ van Erpecum… - … et Biophysica Acta (BBA …, 2012 - Elsevier
The farnesoid X receptor (FXR) is a ligand-activated transcription factor belonging to the
nuclear receptor (NR) superfamily. FXR plays an important role in positively regulating …
nuclear receptor (NR) superfamily. FXR plays an important role in positively regulating …
[HTML][HTML] Nuclear receptor controlof enterohepatic circulation
FJ Gonzalez - Comprehensive Physiology, 2012 - ncbi.nlm.nih.gov
Enterohepatic circulation is responsible for the capture of bile acids and other steroids
produced or metabolized in the liver and secreted to the intestine, for reabsorption back into …
produced or metabolized in the liver and secreted to the intestine, for reabsorption back into …
Knocking on FXR´ s Door: The
C Gege, O Kinzel, C Steeneck, A Schulz… - Current topics in …, 2014 - ingentaconnect.com
The Farnesoid X Receptor (FXR) was recently validated in clinical studies using the bile acid
analogue Obeticholic Acid (OCA) as an attractive drug target for liver diseases such as …
analogue Obeticholic Acid (OCA) as an attractive drug target for liver diseases such as …